Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
10 2021
Historique:
received: 27 07 2021
accepted: 25 08 2021
pubmed: 9 9 2021
medline: 1 10 2021
entrez: 8 9 2021
Statut: ppublish

Résumé

Patients with rheumatic diseases are at increased risk of infectious complications; vaccinations are a critical component of their care. Disease-modifying antirheumatic drugs may reduce the immunogenicity of common vaccines. We will review here available data regarding the effect of these medications on influenza, pneumococcal, herpes zoster, SARS-CoV-2, hepatitis B, human papilloma virus and yellow fever vaccines. Rituximab has the most substantial impact on vaccine immunogenicity, which is most profound when vaccinations are given at shorter intervals after rituximab dosing. Methotrexate has less substantial effect but appears to adversely impact most vaccine immunogenicity. Abatacept likely decrease vaccine immunogenicity, although these studies are limited by the lack of adequate control groups. Janus kinase and tumour necrosis factor inhibitors decrease absolute antibody titres for many vaccines, but do not seem to significantly impact the proportions of patients achieving seroprotection. Other biologics (interleukin-6R (IL-6R), IL-12/IL-23 and IL-17 inhibitors) have little observed impact on vaccine immunogenicity. Data regarding the effect of these medications on the SARS-CoV-2 vaccine immunogenicity are just now emerging, and early glimpses appear similar to our experience with other vaccines. In this review, we summarise the most recent data regarding vaccine response and efficacy in this setting, particularly in light of current vaccination recommendations for immunocompromised patients.

Identifiants

pubmed: 34493491
pii: annrheumdis-2021-221244
doi: 10.1136/annrheumdis-2021-221244
pmc: PMC8494475
mid: NIHMS1738048
doi:

Substances chimiques

Antirheumatic Agents 0
COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1255-1265

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002370
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR072583
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MAF has received consulting fees for Revolo. JTR serves on ACIP HZ Workgroup, lead of ACR COVID Vaccine Guidance Task Force, member of ACR COVID-19 Vaccine Clinical Guideline Task Force, and is a member of EULAR Vaccine Guidance Task Force. JTR receives research grants and/or consulting for unrelated work: Amgen, Abbvie, BMS, CORRONA, Genentech, GSK, Lilly, Janssen, Novartis, Pfizer, UCB. KLW receives support from BMS and Pfizer. KLW has received consulting fees from Pfizer, AbbVie, Union Chimique Belge (UCB), Eli Lilly & Company, Galapagos, GlaxoSmithKline (GSK), Roche, Gilead, BMS, Regeneron, Sanofi, AstraZeneca and Novartis.

Références

N Engl J Med. 2021 Jun 3;384(22):2092-2101
pubmed: 33835769
Med Clin (Barc). 2019 Nov 29;153(10):380-386
pubmed: 31060878
Clin Rheumatol. 2019 May;38(5):1277-1292
pubmed: 30761436
ACR Open Rheumatol. 2020 Jun;2(6):357-361
pubmed: 32412669
Am J Gastroenterol. 2008 Mar;103(3):631-6
pubmed: 17941962
Nat Commun. 2021 Mar 19;12(1):1724
pubmed: 33741972
JAMA Cardiol. 2021 Jun 29;:
pubmed: 34185045
Ann Rheum Dis. 2020 Jan;79(1):39-52
pubmed: 31413005
Lupus. 2020 Jul;29(8):934-942
pubmed: 32501172
Nat Rev Rheumatol. 2019 Feb;15(2):74-75
pubmed: 30622297
Autoimmun Rev. 2014 Jul;13(7):730-5
pubmed: 24657969
Vaccine. 2017 Mar 27;35(14):1764-1769
pubmed: 28268074
Ann Rheum Dis. 2021 Oct;80(10):1357-1359
pubmed: 33975857
Ann Rheum Dis. 2008 May;67(5):713-6
pubmed: 17965123
RMD Open. 2019 Sep 3;5(2):e001018
pubmed: 31565246
Clin Rheumatol. 2011 May;30(5):665-72
pubmed: 21072553
MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27
pubmed: 20671663
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):193-196
pubmed: 33571173
Ann Rheum Dis. 2013 May;72(5):659-64
pubmed: 22589375
J Am Acad Dermatol. 2018 Jun;78(6):1149-1155.e1
pubmed: 29080806
Pediatr Rheumatol Online J. 2020 Feb 22;18(1):19
pubmed: 32087715
J Travel Med. 2020 Sep 26;27(6):
pubmed: 32729905
Arthritis Care Res (Hoboken). 2014 Jul;66(7):1016-26
pubmed: 24339395
Inflamm Bowel Dis. 2020 Mar 4;26(4):593-602
pubmed: 31504526
J Drugs Dermatol. 2013 Oct;12(10):1122-9
pubmed: 24085047
Korean J Hepatol. 2011 Jun;17(2):87-95
pubmed: 21757978
Pediatr Rheumatol Online J. 2020 Nov 11;18(1):87
pubmed: 33176806
Vaccines (Basel). 2021 Feb 28;9(3):
pubmed: 33671007
MMWR Recomm Rep. 2020 Aug 21;69(8):1-24
pubmed: 32820746
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31
pubmed: 29939980
Arthritis Res Ther. 2011;13(5):R174
pubmed: 22024532
J Travel Med. 2018 Jan 1;25(1):
pubmed: 29394383
Ann Rheum Dis. 2006 Feb;65(2):191-4
pubmed: 16014674
Vaccines (Basel). 2021 Jan 18;9(1):
pubmed: 33477534
Rheumatology (Oxford). 2021 Feb 09;:
pubmed: 33560302
Arthritis Rheum. 2012 Sep;64(9):2847-55
pubmed: 22576809
Arthritis Rheumatol. 2015 Feb;67(2):582-3
pubmed: 25418753
Ann Rheum Dis. 2016 Apr;75(4):687-95
pubmed: 25795907
Mod Rheumatol. 2014 May;24(3):511-6
pubmed: 24252023
Arthritis Res Ther. 2020 Feb 22;22(1):36
pubmed: 32087733
MMWR Morb Mortal Wkly Rep. 2021 Jul 09;70(27):977-982
pubmed: 34237049
Arthritis Rheumatol. 2021 Jul;73(7):1093-1107
pubmed: 33728796
N Engl J Med. 2015 May 28;372(22):2087-96
pubmed: 25916341
Nat Rev Drug Discov. 2006 Mar;5(3):185-6
pubmed: 16557658
Rheumatology (Oxford). 2019 Sep 1;58(9):1585-1596
pubmed: 30877773
Hum Vaccin Immunother. 2019;15(5):1177-1182
pubmed: 30676860
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
JAMA Cardiol. 2021 Jun 29;:
pubmed: 34185046
Arthritis Rheum. 2010 Jan;62(1):75-81
pubmed: 20039396
Ann Rheum Dis. 2015 Jul;74(7):1360-7
pubmed: 24618265
Vaccine. 2015 Mar 17;33(12):1446-52
pubmed: 25659279
Ann Rheum Dis. 2021 Mar 23;:
pubmed: 33757968
Ann Rheum Dis. 2008 Jul;67(7):937-41
pubmed: 17981914
Vaccine. 2020 Jan 22;38(4):847-851
pubmed: 31767465
Expert Rev Vaccines. 2014 Aug;13(8):931-4
pubmed: 24935354
Ann Rheum Dis. 2021 Oct;80(10):1355-1356
pubmed: 33958323
Vaccine. 2018 Sep 18;36(39):5832-5845
pubmed: 30122649
J Gen Intern Med. 2005 Aug;20(8):748-53
pubmed: 16050886
Vaccines (Basel). 2020 Aug 14;8(3):
pubmed: 32824111
Rheumatology (Oxford). 2012 Nov;51(11):2091-8
pubmed: 22908326
Ann Rheum Dis. 2021 Oct;80(10):1339-1344
pubmed: 34035003
Hum Vaccin Immunother. 2021 Oct 3;17(10):3481-3483
pubmed: 34015240
Ann Rheum Dis. 2021 Oct;80(10):1330-1338
pubmed: 34127481
Ann Rheum Dis. 2017 Sep;76(9):1559-1565
pubmed: 28468794
Vaccine. 2013 Nov 12;31(47):5572-8
pubmed: 24016810
Immunopharmacology. 2000 May;47(2-3):85-118
pubmed: 10878285
Ann Rheum Dis. 2018 Jun;77(6):898-904
pubmed: 29572291
MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62
pubmed: 20689501
Dermatol Ther. 2021 Jan;34(1):e14684
pubmed: 33331024
Ann Rheum Dis. 2015 May;74(5):818-22
pubmed: 24448345
Blood. 2013 Sep 12;122(11):1946-53
pubmed: 23851398
Arthritis Rheum. 2002 Sep;46(9):2294-300
pubmed: 12355476
Arthritis Res Ther. 2007;9(2):R38
pubmed: 17425783
Rheumatology (Oxford). 2021 Mar 2;60(3):1226-1233
pubmed: 32910152
Vaccine. 2011 Feb 11;29(8):1643-8
pubmed: 21211590
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Arthritis Res Ther. 2010;12(3):R111
pubmed: 20529331
Semin Arthritis Rheum. 2010 Jun;39(6):442-7
pubmed: 19246078
Therapie. 2021 May-Jun;76(3):215-219
pubmed: 32951867
Arthritis Care Res (Hoboken). 2015 May;67(5):731-6
pubmed: 25201241
Ann Intern Med. 2017 Dec 5;167(11):794-804
pubmed: 29159414
Rheumatology (Oxford). 2006 Jan;45(1):106-11
pubmed: 16287919
Arthritis Rheum. 2011 Oct;63(10):3032-7
pubmed: 21953088
Arthritis Res Ther. 2013 Oct 30;15(5):R171
pubmed: 24286269
Pharmacol Rev. 2011 Mar;63(1):127-56
pubmed: 21245206
Arthritis Res Ther. 2015 Jun 06;17:151
pubmed: 26048579
Inflamm Bowel Dis. 2013 Jun;19(7):1441-9
pubmed: 23567780
Rheumatology (Oxford). 2020 Dec 1;59(12):3666-3675
pubmed: 32160295
Arthritis Rheumatol. 2016 Jan;68(1):1-26
pubmed: 26545940
RMD Open. 2019 Sep 19;5(2):e001041
pubmed: 31673420
Vaccine. 2021 Jun 8;39(25):3329-3332
pubmed: 34006408
Arthritis Rheum. 1994 Apr;37(4):481-94
pubmed: 8147925
BMC Rheumatol. 2018 Apr 5;2:12
pubmed: 30886963
Rheumatology (Oxford). 2012 Apr;51(4):695-700
pubmed: 22171015
J Clin Invest. 2020 Dec 1;130(12):6477-6489
pubmed: 32833687
Clin Vaccine Immunol. 2012 Oct;19(10):1597-602
pubmed: 22875601
BioDrugs. 2017 Dec;31(6):545-554
pubmed: 29116597
Arthritis Care Res (Hoboken). 2013 Mar;65(3):476-80
pubmed: 22949223
JAMA. 2021 Apr 6;325(13):1318-1320
pubmed: 33635317
Ann Rheum Dis. 2019 Feb;78(2):282-284
pubmed: 30297326
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33058753
Clin Infect Dis. 2008 May 1;46(9):1459-65
pubmed: 18419456
Vaccines (Basel). 2021 Apr 29;9(5):
pubmed: 33946748
Nat Rev Rheumatol. 2020 Mar;16(3):145-154
pubmed: 32066940
Arthritis Rheum. 2010 Jan;62(1):64-74
pubmed: 20039397
Am J Hematol. 2021 May 1;96(5):534-537
pubmed: 33606296
Clin Liver Dis (Hoboken). 2020 May 07;15(4):162-167
pubmed: 32395244
Hepatology. 2018 Apr;67(4):1560-1599
pubmed: 29405329
Vaccine. 2015 Jul 9;33(30):3444-9
pubmed: 26036945
Ann Rheum Dis. 2013 Jun;72(6):1037-43
pubmed: 22968102
Arthritis Care Res (Hoboken). 2013 Sep;65(9):1522-8
pubmed: 23554297
N Engl J Med. 2021 Jun 3;384(22):2124-2130
pubmed: 33835768
BMC Musculoskelet Disord. 2016 May 26;17:231
pubmed: 27229685
Ann Rheum Dis. 2021 Oct;80(10):1306-1311
pubmed: 33762264
Scand J Rheumatol. 2020 Sep;49(5):353-360
pubmed: 32468899
Curr Dir Autoimmun. 2005;8:140-74
pubmed: 15564720
Ann Rheum Dis. 2014 Aug;73(8):1500-7
pubmed: 23723319
Arthritis Res Ther. 2019 Apr 18;21(1):102
pubmed: 30999933
Am J Gastroenterol. 2012 Oct;107(10):1460-6
pubmed: 23034605
JAMA. 2012 Jul 4;308(1):43-9
pubmed: 22760290
J Infect Dis. 2018 May 5;217(11):1750-1760
pubmed: 29529222
Ann Intern Med. 2020 Mar 3;172(5):337-347
pubmed: 32016359
Vaccine. 2017 Feb 7;35(6):903-908
pubmed: 28081972
Curr Opin Rheumatol. 2021 Mar 1;33(2):155-162
pubmed: 33332890
Gut. 2021 Oct;70(10):1884-1893
pubmed: 33903149
Dig Dis Sci. 2018 Jun;63(6):1532-1540
pubmed: 29594970
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Vaccines (Basel). 2021 Feb 12;9(2):
pubmed: 33673048
Arthritis Rheumatol. 2017 Oct;69(10):1969-1977
pubmed: 28845577
Nat Commun. 2021 Sep 14;12(1):5417
pubmed: 34521836
Vaccine. 2020 May 13;38(23):3934-3941
pubmed: 32295718
Nat Rev Rheumatol. 2020 Aug;16(8):413-414
pubmed: 32499548
Ann Rheum Dis. 2011 Mar;70(3):414-22
pubmed: 21131643
J Rheumatol. 2007 May;34(5):952-7
pubmed: 17444589
Arthritis Care Res (Hoboken). 2010 Jun;62(6):896-8
pubmed: 20535801
Arthritis Rheum. 2011 Dec;63(12):3723-32
pubmed: 21834061

Auteurs

Marcia A Friedman (MA)

Medicine, Oregon Health & Science University, Portland, Oregon, USA friedmam@ohsu.edu.

Jeffrey R Curtis (JR)

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham Department of Medicine, Birmingham, Alabama, USA.

Kevin L Winthrop (KL)

Medicine, Oregon Health & Science University, Portland, Oregon, USA.
School of Public Health, Oregon Health & Science University, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH